iDose TR — A Travoprost Implant for Glaucoma
The Medical Letter on Drugs and Therapeutics · 2024
DOI: 10.58347/tml.2024.1701d ↗Kurz gefasst
Fachartikel in der Zeitschrift The Medical Letter on Drugs and Therapeutics, 2024. Hauptthemen laut MEDLINE: Glaucoma, Travoprost, Drug Implants, Antihypertensive Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
The FDA has approved iDose TR (Glaukos), an intracameral implant containing the prostaglandin analog (PGA) travoprost, for reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
(2024). iDose TR — A Travoprost Implant for Glaucoma. The Medical Letter on Drugs and Therapeutics. https://doi.org/10.58347/tml.2024.1701d
Vancouver
iDose TR — A Travoprost Implant for Glaucoma. The Medical Letter on Drugs and Therapeutics. 2024. doi:10.58347/tml.2024.1701d
BibTeX
@article{euvimed2024,
title = {iDose TR — A Travoprost Implant for Glaucoma},
journal = {The Medical Letter on Drugs and Therapeutics},
year = {2024},
doi = {10.58347/tml.2024.1701d}
}
EUVIMED